Structural and Functional Insights into CRF Peptides and Their Receptors
Open Access
Abstract
Corticotropin-releasing factor or hormone (CRF or CRH) and the urocortins regulate a plethora of physiological functions and are involved in many pathophysiological processes. CRF and urocortins belong to the family of CRF peptides (CRF family), which includes sauvagine, urotensin, and many synthetic peptide and non-peptide CRF analogs. Several of the CRF analogs have shown considerable therapeutic potential in the treatment of various diseases. The CRF peptide family act by interacting with two types of plasma membrane proteins, type 1 (CRF1R) and type 2 (CRF2R), which belong to subfamily B1 of the family B G-protein-coupled receptors (GPCRs). This work describes the structure of CRF peptides and their receptors and the activation mechanism of the latter, which is compared with that of other GPCRs. It also discusses recent structural information that rationalizes the selective binding of various ligands to the two CRF receptor types and the activation of receptors by different agonists.Keywords
Funding Information
- University of Crete (SARF UoC) (10674)
This publication has 128 references indexed in Scilit:
- Design, synthesis, structural optimization, SAR, in silico prediction of physicochemical properties and pharmacological evaluation of novel & potent thiazolo[4,5-d]pyrimidine corticotropin releasing factor (CRF) receptor antagonistsEuropean Journal of Pharmaceutical Sciences, 2022
- Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor ReceptorsMolecular Cell, 2020
- Toward a Structural Understanding of Class B GPCR Peptide Binding and ActivationMolecular Cell, 2020
- The CRF System as a Therapeutic Target for Neuropsychiatric DisordersTrends in Pharmacological Sciences, 2016
- Genetically Encoded Chemical Probes in Cells Reveal the Binding Path of Urocortin-I to CRF Class B GPCRCell, 2013
- Progress in corticotropin-releasing factor-1 antagonist developmentDrug Discovery Today, 2010
- Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivityNeuropharmacology, 2004
- Structure–Activity Studies on the Corticotropin Releasing Factor Antagonist Astressin, leading to a Minimal Sequence necessary for Antagonistic ActivityChemBioChem, 2004
- Animal Models of CRH DeficiencyFrontiers in Neuroendocrinology, 1999
- Isolation and sequence analysis of the human corticotropin‐releasing factor precursor gene.The EMBO Journal, 1983